UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000055674
Receipt number R000063586
Scientific Title Observational study to investigate safety and effectiveness of lorlatinib as first line treatment for ALK-gene rearranged unresectable advanced/recurrent NSCLC patients in Japan clinical setting
Date of disclosure of the study information 2024/10/01
Last modified on 2025/04/03 10:08:52

No. Disposal Last modified on Item of update
1 Insert 2024/09/30 10:06:05
2 Update 2025/01/31 14:36:08 Key inclusion criteria
Key inclusion criteria
3 Update 2025/04/03 10:05:53
Last name of contact person

Last name of contact person
Name of person sending information
Name of person sending information
Email1
4 Update 2025/04/03 10:08:52 Email